Shopping Cart
Remove All
  • TargetMol
    Your shopping cart is currently empty
Filter
Applied FilterClear all
TargetMol | Tags By Target
  • CDK
    (3)
  • FLT
    (3)
  • JAK
    (3)
  • Cysteine Protease
    (1)
  • SARS-CoV
    (1)
  • Virus Protease
    (1)
  • Others
    (1)
TargetMol | Tags By ResearchField
  • Cancer
    (3)
Filter
Search Result
Results for "

tg 02

" in TargetMol Product Catalog.
  • Inhibitors & Agonists
    5
    TargetMol | All_Pathways
SB1317
TG02
T26531204918-72-8
SB1317 (TG02) is a potent inhibitor of cyclin dependant kinases (CDKs), Janus kinase 2 (JAK2), and Fms-like tyrosine kinase-3 (FLT3).
  • $30
In Stock
Size
QTY
TargetMol | Citations Cited
H 35-25
T7089513549-60-5
H 35-25 is a beta 2-antagonist.
    Inquiry
    SB1317 hydrochloride (1204918-72-8(free base))
    TG-02 hydrochloride
    T4227
    SB1317 hydrochloride (1204918-72-8(free base)) (TG-02 hydrochloride) is an effective inhibitor of CDK2/JAK2/FLT3 (IC50: 13/73/56 nM).
    • $45
    In Stock
    Size
    QTY
    (E/Z)-Zotiraciclib
    (E/Z)-TG02, (E/Z)-SB1317
    T21503937270-47-8
    (E/Z)-Zotiraciclib ((E/Z)-TG02) effectively inhibits CDK2, JAK2, and FLT3 with IC50s of 13 nM, 73 nM, and 56 nM, respectively.
    • $38
    In Stock
    Size
    QTY
    MPI8 TFA
    TG0205221 TFA
    T215104
    MPI8 (TG0205221) TFA is an inhibitor specifically designed for SARS-CoV-2 main protease (MPro), exhibiting significant antiviral activity. Its antiviral effects are achieved through the dual and selective inhibition of both SARS-CoV-2 MPro and the host cell's cysteine protease L (cathepsin L). MPI8 TFA is applicable for clinical research related to COVID-19.
    • Inquiry Price
    Inquiry
    Size
    QTY